Policies on children and schools during the SARS-CoV-2 pandemic in Western Europe

COVID-19; Children; MitigationCOVID-19; Nens; MitigacióCOVID-19; Niños; MitigaciónDuring the pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), mitigation policies for children have been a topic of considerable uncertainty and debate. Although some children have co-morbidities which increase their risk for severe coronavirus disease (COVID-19), and complications such as multisystem inflammatory syndrome and long COVID, most children only get mild COVID-19. On the other hand, consistent evidence shows that mass mitigation measures had enormous adverse impacts on children. A central question can thus be posed: What amount of mitigation should children bear, in response to a disease that is disproportionally affecting older people? In this review, we analyze the distinct child versus adult epidemiology, policies, mitigation trade-offs and outcomes in children in Western Europe. The highly heterogenous European policies applied to children compared to adults did not lead to significant measurable differences in outcomes. Remarkably, the relative epidemiological importance of transmission from school-age children to other age groups remains uncertain, with current evidence suggesting that schools often follow, rather than lead, community transmission. Important learning points for future pandemics are summarized

Policies on children and schools during the SARS-CoV-2 pandemic in Western Europe.

During the pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), mitigation policies for children have been a topic of considerable uncertainty and debate. Although some children have co-morbidities which increase their risk for severe coronavirus disease (COVID-19), and complications such as multisystem inflammatory syndrome and long COVID, most children only get mild COVID-19. On the other hand, consistent evidence shows that mass mitigation measures had enormous adverse impacts on children. A central question can thus be posed: What amount of mitigation should children bear, in response to a disease that is disproportionally affecting older people? In this review, we analyze the distinct child versus adult epidemiology, policies, mitigation trade-offs and outcomes in children in Western Europe. The highly heterogenous European policies applied to children compared to adults did not lead to significant measurable differences in outcomes. Remarkably, the relative epidemiological importance of transmission from school-age children to other age groups remains uncertain, with current evidence suggesting that schools often follow, rather than lead, community transmission. Important learning points for future pandemics are summarized

Knowledge and attitudes of medical students about clinical aspects of congenital cytomegalovirus infection in newborns: A nationwide cross-sectional study in Greece

IntroductionCytomegalovirus (CMV) is the most frequent cause of congenital infection worldwide causing severe morbidity in newborns, infants, and children. Despite the clinical importance of congenital CMV (cCMV) infection, studies conducted so far indicate that there is limited awareness in the medical community in the field. The aim of this study was to assess Greek medical students’ knowledge on cCMV infection.MethodsWe performed a questionnaire-based nationwide cross-sectional study. A convenience sample of medical students from seven medical schools was enrolled.ResultsOf the 562 respondents, 54,8% considered themselves undereducated on cCMV infection. However, almost half of the participants could correctly recognize some basic principles of cCMV infection including ways of transmission, diagnosis and treatment, while there were aspects of cCMV infection with knowledge deficit. The year of study had a positive impact on the level of knowledge with students of higher years of study being of more sufficient education on the specific topic.ConclusionOverall, our study indicates a discrepancy between self-reported awareness and the level of knowledge among medical students in Greece. Further educational opportunities about cCMV should be offered, particularly in areas of the curriculum involving the care of women and children. Establishing medical students’ solid background on the disease burden and educating them about preventative strategies for at-risk populations, should be the main pillars of such efforts in order to promote confidence in managing these cases in their future professional careers

Extremely Preterm Infant Admissions Within the SafeBoosC-III Consortium During the COVID-19 Lockdown

Objective: To evaluate if the number of admitted extremely preterm (EP) infants (born before 28 weeks of gestational age) differed in the neonatal intensive care units (NICUs) of the SafeBoosC-III consortium during the global lockdown when compared to the corresponding time period in 2019. Design: This is a retrospective, observational study. Forty-six out of 79 NICUs (58%) from 17 countries participated. Principal investigators were asked to report the following information: (1) Total number of EP infant admissions to their NICU in the 3 months where the lockdown restrictions were most rigorous during the first phase of the COVID-19 pandemic, (2) Similar EP infant admissions in the corresponding 3 months of 2019, (3) the level of local restrictions during the lockdown period, and (4) the local impact of the COVID-19 lockdown on the everyday life of a pregnant woman. Results: The number of EP infant admissions during the first wave of the COVID-19 pandemic was 428 compared to 457 in the corresponding 3 months in 2019 (−6.6%, 95% CI −18.2 to +7.1%, p = 0.33). There were no statistically significant differences within individual geographic regions and no significant association between the level of lockdown restrictions and difference in the number of EP infant admissions. A post-hoc analysis based on data from the 46 NICUs found a decrease of 10.3%in the total number of NICU admissions (n = 7,499 in 2020 vs. n = 8,362 in 2019). Conclusion: This ad hoc study did not confirm previous reports of a major reduction in the number of extremely pretermbirths during the first phase of the COVID-19 pandemic. Clinical Trial Registration: ClinicalTrial.gov, identifier: NCT04527601 (registered August 26, 2020), https://clinicaltrials.gov/ct2/show/NCT04527601

Achaiki Iatriki : official publication of the medical society of western Greece and Peloponnesus

In the current issue, the editorial by Cauchi et al. argues for eco-friendly measures in endoscopy and emphasies the role of healthcare providers in reducing waste. The editorial adeptly employs the three Rs (Reduce, Reuse, Recycle) framework to tackle waste management, offering practical solutions. The editorial by Milionis et al. focuses on the reverse cascade screening for paediatric familial hypercholesterolaemia (FH), which is an upcoming tool for public health. Advantages, practices, and challenges regarding FH are thoroughly discussed. Lastly, the editorial by Fousekis et al. presents the main aspects of a chronic immune-mediated cutaneous disease, dermatitis herpetiformis (DH), which constitutes an extraintestinal manifestation of celiac disease, including its diagnosis, pathogenesis, and management. Moreover, this issue includes three review articles. The review article by Krontira et al. discusses the evolving data on the epidemiology, diagnostic approach and appropriate management of foreign body and caustic substance ingestion, based on updated guidelines published by gastroenterological and endoscopic societies. The review by Halliasos et al. provides data on the clinical presentation, diagnosis, and management of metastatic acute spinal cord compression, focusing on the importance of a multidisciplinary team approach, including spine surgeons, radiation oncologists, medical oncologists, palliative care clinicians, physiotherapists, and psychologists. Lastly, the review by Schinas et al. outlines the potential of immune modulation in the treatment of infections and the need for individualised approaches in the modern world of personalised medicine by examining some of the key strategies and immune-based therapies being developed to combat infectious diseases.peer-reviewe

Predicting the next pandemic: VACCELERATE ranking of the World Health Organization's Blueprint for Action to Prevent Epidemics

Introduction: The World Health Organization (WHO)'s Research and Development (R&D) Blueprint for Action to Prevent Epidemics, a plan of action, highlighted several infectious diseases as crucial targets for prevention. These infections were selected based on a thorough assessment of factors such as transmissibility, infectivity, severity, and evolutionary potential. In line with this blueprint, the VACCELERATE Site Network approached infectious disease experts to rank the diseases listed in the WHO R&D Blueprint according to their perceived risk of triggering a pandemic. VACCELERATE is an EU-funded collaborative European network of clinical trial sites, established to respond to emerging pandemics and enhance vaccine development capabilities. Methods: Between February and June 2023, a survey was conducted using an online form to collect data from members of the VACCELERATE Site Network and infectious disease experts worldwide. Participants were asked to rank various pathogens based on their perceived risk of causing a pandemic, including those listed in the WHO R&D Blueprint and additional pathogens. Results: A total of 187 responses were obtained from infectious disease experts representing 57 countries, with Germany, Spain, and Italy providing the highest number of replies. Influenza viruses received the highest rankings among the pathogens, with 79 % of participants including them in their top rankings. Disease X, SARS-CoV-2, SARS-CoV, and Ebola virus were also ranked highly. Hantavirus, Lassa virus, Nipah virus, and henipavirus were among the bottom-ranked pathogens in terms of pandemic potential. Conclusion: Influenza, SARS-CoV, SARS-CoV-2, and Ebola virus were found to be the most concerning pathogens with pandemic potential, characterised by transmissibility through respiratory droplets and a reported history of epidemic or pandemic outbreaks

The levels of fibroblast growth 23 FGF23 and klotho protein in association with age and renal phosphate tubular reabsorption in childhood

Background: Phosphate serum levels in children vary with age. Fibroblast Growth Factor 23 (FGF23) is a phosphaturic hormone that plays an important role in phosphate homeostasis. Klotho is the essential co-player of FGF23 that mediates the binding of FGF23 to its receptor. Data for fibroblast growth factor 23 (FGF23) and particularly for Klotho in healthy children are limited.Objective and hypotheses: We aimed to investigate the relationship between FGF23 and Klotho serum levels with age and TmP/GFR and to evaluate parameters that might affect FGF23 and Klotho.Methods: In 159 healthy children (82 boys) with a mean ± SD age of 8.78 ± 3.47 years we measured FGF23 (intact FGF23/ iFGF23 and C-terminal FGF23/ cFGF23) and soluble Klotho (sKlotho) serum levels by ELISA. We also determined the TmP/GFR.Results: Mean ± SD value for cFGF23 was 51.14 ±12.79 RU/ml whereas median (range) values for iFGF23 and Klotho were 35 (8.8, 120) pg/ml and 1945 (372, 5866) pg/ml respectively. Neither FGF23 nor Klotho were significantly associated with age. Pubertal children had higher Klotho (p < 0.05). Girls had higher levels of cFGF23 (p < 0.05) and Klotho (p < 0.001). Serum phosphate and TmP/GFR were positively associated with cFGF23 (p < 0.01 and p < 0.001), iFGF23 (p < 0.05 and p < 0.001) and sKlotho (p < 0.05 and p < 0.01). Klotho was positively correlated with IGF-I (p < 0.0001) and 1,25 (OH)2 vitamin D (p < 0.05).Conclusions: We provide data on FGF23, and Klotho measured simultaneously in healthy children. The positive association of serum phosphate and TmP/GFR with FGF23 and Klotho suggests that they have a counterregulatory effect on phosphate homeostasis. The strong association of Klotho with IGF-I could indicate a role of Klotho in linear growth through regulation of phosphate homeostasis, but further studies are required.Εισαγωγή: Τα επίπεδα φωσφόρου αλλάζουν με την ηλικία. Ο αυξητικός παράγοντας των ινοβλαστών 23 (FGF23) είναι μία φωσφατουρική ορμόνη που παίζει σημαντικό ρόλο στην ομοιόσταση φωσφόρου. Η πρωτεΐνη Klotho είναι ο συμπαράγοντας του FGF23 που μεσολαβεί τη σύνδεση του FGF23 στον υποδοχέα του. Στη βιβλιογραφία για τα υγιή παιδιά υπάρχουν λίγα δεδομένα για τον FGF23 και ακόμη λιγότερα για το Klotho.Σκοπός μελέτης: Nα διερευνήσουμε την ύπαρξη πιθανής συσχέτισης μεταξύ των κυκλοφορούντων επιπέδων FGF23 και Klotho με την ηλικία και το ρυθμό μέγιστης σωληναριακής επαναρρόφησης φωσφόρου (TmP/GFR) και να μελετήσουμε τις παραμέτρους που τυχόν επηρεάζουν τα επίπεδα FGF23 και Klotho. Μέθοδοι: Σε 159 υγιή παιδιά (82 αγόρια) με μέση ± SD ηλικία 8.78 ± 3.47 έτη μετρήθηκε ο FGF23 (τόσο ο iFGF23 όσο και ο cFGF23) και το κυκλοφορούν Klotho (sKlotho) με τεχνικές ELISA. Υπολογίσαμε επίσης τα επίπεδα του TmP/GFR.Αποτελέσματα: Η μέση τιμή ± SD του cFGF23 ήταν 51.14 ± 12.79 RU/ml ενώ η διάμεσος (εύρος) του iFGF23 και του Klotho ήταν 35 (8.8, 120) pg/ml and 1945 (372, 5866) pg/ml αντιστοίχως. Ούτε ο FGF23 αλλά ούτε και το Klotho δε σχετίζονταν με την ηλικία. Τα παιδιά που είχαν μπει στην εφηβεία είχαν υψηλότερα επίπεδα Klotho (p < 0.05). Τα κορίτσια είχαν υψηλότερα επίπεδα cFGF23 (p < 0.05) και Klotho (p < 0.001). Τα επίπεδα του κυκλοφορούντος φωσφόρου και TmP/GFR ήταν θετικώς συσχετιζόμενα με τον cFGF23 (p < 0.01 και p < 0.001), iFGF23 (p < 0.05 και p < 0.001) και Klotho (p < 0.05 και p < 0.01). Το Klotho ήταν θετικώς συσχετιζόμενο με τον IGF-I (p < 0.0001) και 1,25 (OH)2 βιταμίνη D (p < 0.05).Συμπεράσματα: Στην παρούσα μελέτη παρουσιάζουμε δεδομένα για τα επίπεδα cFGF23, iFGF23, και Klotho που μετρήθηκαν ταυτόχρονα σε υγιή παιδιά. Η θετική συσχέτιση μεταξύ κυκλοφορούντος φωσφόρου και TmP/GFR με τον FGF23 και το Klotho υποδηλώνει ότι έχουν έναν αντισταθμιστικό ρόλο στην ομοιόσταση φωσφόρου. Η ισχυρή συσχέτιση μεταξύ Klotho και IGF-I μπορεί να σημαίνει ότι το Klotho έχει κάποιο ρόλο στην κατά μήκος ανάπτυξη κατά την παιδική ηλικία μέσω ρύθμισης της ομοιόστασης του φωσφόρου αλλά περισσότερες μελέτες χρειάζονται για να διευκρινιστεί αυτό περαιτέρω

Knowledge, Attitudes and Perceptions of Medical Students on Antimicrobial Stewardship

Antimicrobial Resistance (AMR) is an ongoing threat to modern medicine throughout the world. The World Health Organisation has emphasized the importance of adequate and effective training of medical students in wise prescribing of antibiotics Furthermore, Antimicrobial Stewardship (AMS) has been recognized as a rapidly growing field in medicine that sets a goal of rational use of antibiotics in terms of dosing, duration of therapy and route of administration. We undertook the current review to systematically summarize and present the published data on the knowledge, attitudes and perceptions of medical students on AMS. We reviewed all studies published in English from 2007 to 2020. We found that although medical students recognize the problem of AMR, they lack basic knowledge regarding AMR. Incorporating novel and effective training methods on all aspects of AMS and AMR in the Medical Curricula worldwide is of paramount importance

Nutrition of Infants with Bronchopulmonary Dysplasia before and after Discharge from the Neonatal Intensive Care Unit

Bronchopulmonary dysplasia (BPD) represents a severe sequela in neonates born very prematurely. The provision of adequate nutritional support in this high-risk population is challenging. The development of the lungs and physical growth are closely linked together in infants with BPD. Growth deficiency has been associated with pulmonary dysfunction, whereas improvement in respiratory status results in growth acceleration. Currently, there is not enough data regarding optimal nutritional strategies in this population. Nutrition in these infants should provide sufficient calories and nutrients to establish growth, avoid growth retardation and assist alveolarization of the lungs. Meticulous follow-up is mandatory during and after discharge from the Neonatal Intensive care Unit (NICU) to minimize growth retardation and improve lung function. Despite the significant literature supporting the contribution of growth and nutrition in the avoidance of BPD, there is limited research regarding interventions and management of infants with established BPD. Our aim was to review clinical strategies applied in everyday clinical practice and identify debates on the nutritional approach of newborns with BPD. Well-organized interventions and clinical trials regarding the somatic development and nutrition of infants with BPD are warranted

Infantile hemangiomas screening modalities for primary care physicians

ABSTRACT Infantile hemangiomas are the most common benign vascular tumors in children. They present a characteristic natural history of spontaneous involution after a phase of initial proliferation. A small but significant minority demonstrates incomplete regression or complications and requires prompt intervention. Prediction of the evolution of infantile hemangiomas is challenging because of their morphological and behavioral heterogeneity. The decision between referral for treatment and observation is sometimes difficult, especially among non‐expert physicians, with the risk of missing the period for optimizing outcomes in case of delayed intervention. The aim of this review is to update our knowledge, especially of the primary care providers, regarding the ongoing difficulties of the early clinical evaluation of infantile hemangiomas, and to outline the importance of current practical scoring tools for the identification of the lesions which require expert consultation and referral